Filed: 11/14/2022ACC: 0001420506-22-002295
📋 What this filing means
IKARIAN CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 83 equity positions with a total reported market value of $501.8K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
83
Positions
$501.8K
Total AUM (reported)
38.24M
Total Shares
Allocation by class
COM$399.1K79.5%
COM NEW$41.6K8.3%
TR UNIT$21.4K4.3%
SHS$14.4K2.9%
S&P BIOTECH$11.9K2.4%
CL A$4.0K0.8%
GENOMIC REV ETF$3.2K0.6%
Portfolio Concentration
Top 3$118.8K23.7%
4–10$142.1K28.3%
11–25$141.6K28.2%
Rest$99.4K19.8%
Top 3 weight
23.7%
Top 10 weight
52.0%
Voting Authority Distribution
Total shares with voting rights: 38.24M
Sole
Full voting authority
38.24M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole83
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings83
Rows:
RELMADA THERAPEUTICS INC
SOLEShares1.55M
TypeSH
Market value$57.4K
11.44%
Sole
1.55M
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares134.66K
TypeSH
Market value$36.0K
7.16%
Sole
134.66K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares1.42M
TypeSH
Market value$25.4K
5.06%
Sole
1.42M
Shared
0.00
None
0.00
DICE THERAPEUTICS INC
SOLEShares1.25M
TypeSH
Market value$25.4K
5.06%
Sole
1.25M
Shared
0.00
None
0.00
PROMETHEUS BIOSCIENCES INC
SOLEShares409.18K
TypeSH
Market value$24.1K
4.81%
Sole
409.18K
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares60K
TypeSH
Market value$21.4K
4.27%
Sole
60K
Shared
0.00
None
0.00
SEAGEN INC
SOLEShares150K
TypeSH
Market value$20.5K
4.09%
Sole
150K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares407.60K
TypeSH
Market value$18.2K
3.62%
Sole
407.60K
Shared
0.00
None
0.00
ALTIMMUNE INC
SOLEShares1.31M
TypeSH
Market value$16.8K
3.35%
Sole
1.31M
Shared
0.00
None
0.00
ESPERION THERAPEUTICS INC NE
SOLEShares2.33M
TypeSH
Market value$15.6K
3.11%
Sole
2.33M
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares1.15M
TypeSH
Market value$13.8K
2.76%
Sole
1.15M
Shared
0.00
None
0.00
TRICIDA INC
SOLEShares1.31M
TypeSH
Market value$13.7K
2.73%
Sole
1.31M
Shared
0.00
None
0.00
MILESTONE PHARMACEUTICALS IN
SOLEShares1.37M
TypeSH
Market value$12.6K
2.52%
Sole
1.37M
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares150K
TypeSH
Market value$11.9K
2.37%
Sole
150K
Shared
0.00
None
0.00
DECIPHERA PHARMACEUTICALS IN
SOLEShares614.88K
TypeSH
Market value$11.4K
2.27%
Sole
614.88K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares102.01K
TypeSH
Market value$11.3K
2.25%
Sole
102.01K
Shared
0.00
None
0.00
BELLUS HEALTH INC NEW
SOLEShares935.33K
TypeSH
Market value$9.9K
1.97%
Sole
935.33K
Shared
0.00
None
0.00
HORIZON THERAPEUTICS PUB L
SOLEShares159.32K
TypeSH
Market value$9.9K
1.96%
Sole
159.32K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares317.48K
TypeSH
Market value$8.9K
1.78%
Sole
317.48K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares250K
TypeSH
Market value$7.0K
1.40%
Sole
250K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares95.20K
TypeSH
Market value$6.6K
1.32%
Sole
95.20K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares699.44K
TypeSH
Market value$6.3K
1.26%
Sole
699.44K
Shared
0.00
None
0.00
KEZAR LIFE SCIENCES INC
SOLEShares728.59K
TypeSH
Market value$6.3K
1.25%
Sole
728.59K
Shared
0.00
None
0.00
SAGE THERAPEUTICS INC
SOLEShares157.81K
TypeSH
Market value$6.2K
1.23%
Sole
157.81K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares160.49K
TypeSH
Market value$5.8K
1.15%
Sole
160.49K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RELMADA THERAPEUTICS INCSOLE | COM | 1.55M | SH | $57.4K 11.44% | 1.55M | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 134.66K | SH | $36.0K 7.16% | 134.66K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 1.42M | SH | $25.4K 5.06% | 1.42M | 0.00 | 0.00 |
DICE THERAPEUTICS INCSOLE | COM | 1.25M | SH | $25.4K 5.06% | 1.25M | 0.00 | 0.00 |
PROMETHEUS BIOSCIENCES INCSOLE | COM | 409.18K | SH | $24.1K 4.81% | 409.18K | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 60K | SH | $21.4K 4.27% | 60K | 0.00 | 0.00 |
SEAGEN INCSOLE | COM | 150K | SH | $20.5K 4.09% | 150K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 407.60K | SH | $18.2K 3.62% | 407.60K | 0.00 | 0.00 |
ALTIMMUNE INCSOLE | COM NEW | 1.31M | SH | $16.8K 3.35% | 1.31M | 0.00 | 0.00 |
ESPERION THERAPEUTICS INC NESOLE | COM | 2.33M | SH | $15.6K 3.11% | 2.33M | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 1.15M | SH | $13.8K 2.76% | 1.15M | 0.00 | 0.00 |
TRICIDA INCSOLE | COM | 1.31M | SH | $13.7K 2.73% | 1.31M | 0.00 | 0.00 |
MILESTONE PHARMACEUTICALS INSOLE | COM | 1.37M | SH | $12.6K 2.52% | 1.37M | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 150K | SH | $11.9K 2.37% | 150K | 0.00 | 0.00 |
DECIPHERA PHARMACEUTICALS INSOLE | COM | 614.88K | SH | $11.4K 2.27% | 614.88K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 102.01K | SH | $11.3K 2.25% | 102.01K | 0.00 | 0.00 |
BELLUS HEALTH INC NEWSOLE | COM NEW | 935.33K | SH | $9.9K 1.97% | 935.33K | 0.00 | 0.00 |
HORIZON THERAPEUTICS PUB LSOLE | SHS | 159.32K | SH | $9.9K 1.96% | 159.32K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 317.48K | SH | $8.9K 1.78% | 317.48K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 250K | SH | $7.0K 1.40% | 250K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 95.20K | SH | $6.6K 1.32% | 95.20K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 699.44K | SH | $6.3K 1.26% | 699.44K | 0.00 | 0.00 |
KEZAR LIFE SCIENCES INCSOLE | COM | 728.59K | SH | $6.3K 1.25% | 728.59K | 0.00 | 0.00 |
SAGE THERAPEUTICS INCSOLE | COM | 157.81K | SH | $6.2K 1.23% | 157.81K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 160.49K | SH | $5.8K 1.15% | 160.49K | 0.00 | 0.00 |
Page 1 of 4